Ditchcarbon
  • Contact
  1. Organizations
  2. Daewoong Pharmaceutical
Public Profile
Pharmaceutical Preparation Manufacturing
IN
updated 23 days ago

Daewoong Pharmaceutical

Company website

Daewoong Pharmaceutical Co., Ltd., commonly referred to as Daewoong, is a leading South Korean pharmaceutical company headquartered in Incheon, South Korea. Established in 1945, Daewoong has made significant strides in the pharmaceutical industry, focusing on research and development, manufacturing, and marketing of innovative medicines. The company operates extensively across Asia, Europe, and the Americas, with a diverse portfolio that includes prescription drugs, over-the-counter products, and biopharmaceuticals. Notable for its commitment to innovation, Daewoong has developed unique therapies in areas such as gastroenterology, neurology, and endocrinology. With a strong market position, Daewoong has achieved several milestones, including the successful launch of its biosimilar products, which have garnered recognition for their quality and efficacy. As a forward-thinking organisation, Daewoong Pharmaceutical continues to contribute to global health advancements.

DitchCarbon Score

How does Daewoong Pharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

30

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Daewoong Pharmaceutical's score of 30 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.

52%

Let us know if this data was useful to you

Daewoong Pharmaceutical's reported carbon emissions

In 2024, Daewoong Pharmaceutical reported total carbon emissions of approximately 32,000,000 kg CO2e, comprising about 9,675,000 kg CO2e from Scope 1 and about 23,296,000 kg CO2e from Scope 2 emissions. This marks a decrease from 2023, where emissions totalled around 34,706,000 kg CO2e, with Scope 1 emissions at about 10,184,000 kg CO2e and Scope 2 emissions at approximately 24,522,000 kg CO2e. The company has not disclosed any Scope 3 emissions data, indicating a focus on direct and indirect emissions from its operations and energy use. Despite the absence of specific reduction targets or initiatives, Daewoong Pharmaceutical is committed to sustainability, as evidenced by its ongoing emissions reporting and transparency. The emissions data is not cascaded from any parent organisation, and all figures are sourced directly from Daewoong Pharmaceutical Co., Ltd. The company continues to monitor its carbon footprint as part of its broader climate commitments.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20202021202220232024
Scope 1
-
0,000,000
00,000,000
00,000,000
0,000,000
Scope 2
35,843,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 3
-
-
-
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Daewoong Pharmaceutical's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Daewoong Pharmaceutical is in IN, which has a very high grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Daewoong Pharmaceutical is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Samsung Biologics

KR
•
Pharmaceutical Preparation Manufacturing
Updated 20 days ago

Nautilus Biotech S.A.

FR
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Takeda

JP
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Bruschettini Srl

IT
•
Pharmaceutical Preparation Manufacturing
Updated 26 days ago

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Revance Therapeutics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 28 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251005.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy